spacer
home > white papers > Translating Cancer Genomics Into A Personalised Approach For Cancer Patients - PRA Health Sciences (PRA)
WHITE PAPERS
logo_PRA_Healthk.jpg

PRA Health Sciences (PRA)

phone +44 (118) 918-1000
email prahealthsciences@prahs.com
web http://www.prahs.com
email Green Park, 500 South Oak Way, Reading, RG2 6AD UK

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patientís particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

FlyPharma Conference Europe: New dates and location announced

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022. Taking place in Leipzig, Germany on 19-21 September, FlyPharma Europe will bring together a global audience of (bio)pharma logistics professionals to discuss and debate the latest supply chain challenges and industry best practices.
More info >>


White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement